Lọc tín hiệu
DTP

DTP

Ha Noi CPC1 Pharmaceutical
PharmaceuticalsUPCOM
Same sector:AGPAMPBCHBCPBIOCDPCNCDANDBDDBM
58.800
−2,00%
2026-10-19

Fundamental Analysis

44 / 100BRubric: Manufacturing
Quarterly resultsRelative Valuation
CriterionLatest Q EPS growth (YoY)Avg EPS growth, last 3 (YoY)Quarters with EPS growthRevenue growth (YoY)Gross margin change (pp, YoY)Net margin change (pp, YoY)Return on Equity (TTM)Financial health (Debt/Equity)Valuation (P/E vs 5-yr median)Revenue (bn)Rev YoYNPAT (bn)NPAT YoYP/E5-Year Median P/EP/E vs. 5-Year Median
Value-8.8%+7.7%1 / 3+17.5%-5.73 pp-3.63 pp+22.6%0.107.27463+17,5%58,2−8,8%7.279.47−23,2%
Pts004800121212
Valuation annotation:Price: 58.800 (close price on 2026-10-19)EPS (TTM): 8.083

Financial charts

1.Revenue & growth

VND bn463Q2/26

1.Revenue & growth

VND bn463Q2/26

2.Profit & growth

VND bn57,4Q2/26

3.Profit mix (Penman)

VND bn307Q2/26

4.Margins & cost structure

%51.3%Q2/26

5.Returns & cash cycle

% · days23.5%Q2/26

6.Earnings quality & cash

VND bn311Q2/26

7.Asset structure

VND bn1.648Q2/26

8.Funding & debt health

VND bn · times1.648Q2/26

9.Revenue backlog

VND bn78,6Q2/26

10.Valuation

times · %8,7×Q2/26

11.EPS growth & dilution warning (CANSLIM)

VND per share; growth in %1.415Q2/26
Adjusted EPS growth, latest quarter
-10.1%
Average adjusted EPS growth, 3 quarters
7.3%
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
-0.0%

Source: vnstockData through Q2/26